Moore, L., Baris, D., Figueroa, J., Garcia-Closas, M., Karagas, M., Schwenn, M., . . . Rothman, N. (2011). GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: Results from the New England bladder cancer study and NAT2 meta-analysis. Oxford University Press.
Citação norma ChicagoMoore, L.E., et al. GSTM1 Null and NAT2 Slow Acetylation Genotypes, Smoking Intensity and Bladder Cancer Risk: Results From the New England Bladder Cancer Study and NAT2 Meta-analysis. Oxford University Press, 2011.
Citação norma MLAMoore, L.E., et al. GSTM1 Null and NAT2 Slow Acetylation Genotypes, Smoking Intensity and Bladder Cancer Risk: Results From the New England Bladder Cancer Study and NAT2 Meta-analysis. Oxford University Press, 2011.